The fourth meeting of the Federal Government’s Pharma Dialogue took place on 21 January 2015. This time the aim was to carry out a comprehensive review of previous dialogue meetings.
The German biotechnology sector is beginning the new year on its most optimistic note in quite some time and is confident that further growth lies ahead.
The Federal Ministry of Health (BMG) held discussions with experts on the rules contained in theministerial draft bill on the Fourth Act Amending the Regulations on Medicinal Products and Other Regulations (Medicinal Products Act Amendment) that pertain to the implementation of the EU regulation governing the conducting and supervision of clinical trials in Europe.
The seventh annual German Biotechnology Days conference will take place in Leipzig on 26 and 27 April 2016. The conference is put on by BIO Deutschland, the Council of German BioRegions, the regional host biosaxony and the regional partner TGZ/Bio-Centre Halle.
In autumn 2016 in Berlin,the German Healthcare Partnership (GHP) and BIO Deutschland will be presenting the German International Healthcare Sector Award for the first time.
BIO Deutschland andtheCouncil of German BioRegions decided last year to collect data jointly in the future on Germany’s biotechnology sector.